Shares of Liminatus Pharma rose after the company shared plans to collaborate on developing a diagnostic kit for detecting pancreatic cancer. The stock advanced 3.7%, to $9.35, in after-hours trading ...

The GOP megabill has new tax breaks aimed at low- and moderate-income households, and spending cuts that could make it harder ...

Shares of online travel-services provider Expedia Group Inc. were heading for their best day in two months on Thursday, as ...